Key result
Prostaglandin E1 effects on peripheral vascular disease cannot be determined due to unavailable data.
Authors
Loading...
Objective effects of prostaglandin E1 in peripheral vascular disease remain undetermined; leaves open need for complete trial data.
Martin et al. (1980) studied Peripheral Vascular Disease. Prostaglandin E1 was evaluated on Objective measurements of peripheral vascular disease. The abstract text is unavailable, so the effects of Prostaglandin E1 on objective measurements of peripheral vascular disease cannot be determined.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: